Radicava Sales Uptake Key to Maintaining Flat Top-Line Over the Next 3-5 Years
We reiterate our “Equal-weight” rating on the stock after reviewing our model post FY17 (YE Mar-18) earningsDomestic pharma, contributing >70%...
854 Views
Mitsubishi Tanabe FY17 Earnings - First Glance
Mitsubishi Tanabe Pharma (4508 JP) reported FY17 results on May, 09 2018 Brisk uptake of recently launched Radicava in the US drove FY17 top-line...
84 Views
Names that Are Hated and Loved by the Street in Japan....
It has been a while since we updated the "Hated by the Street" screen. So we thought it would be good to see which names made the list. Usually we...
297 Views
Sectors Not Correlated to TOPIX - Retailing, Food & Staples Retailing, and Utilities
We recently published a piece looking at Sectors that are highly correlated to TOPIX. In the piece, we highlight the other side. Sectors that are...
269 Views
Names Potentially Well Positioned to Beat Year-End Estimates
With a good portion of Japanese companies having already announced 1H results, we looked at the names that are well positioned for the second half....
486 Views